490 related articles for article (PubMed ID: 25765348)
41. The effects of minoxidil, 1% pyrithione zinc and a combination of both on hair density: a randomized controlled trial.
Berger RS; Fu JL; Smiles KA; Turner CB; Schnell BM; Werchowski KM; Lammers KM
Br J Dermatol; 2003 Aug; 149(2):354-62. PubMed ID: 12932243
[TBL] [Abstract][Full Text] [Related]
42. A Randomized, Controlled Pilot Trial Comparing Platelet-Rich Plasma to Topical Minoxidil Foam for Treatment of Androgenic Alopecia in Women.
Bruce AJ; Pincelli TP; Heckman MG; Desmond CM; Arthurs JR; Diehl NN; Douglass EJ; Bruce CJ; Shapiro SA
Dermatol Surg; 2020 Jun; 46(6):826-832. PubMed ID: 31574029
[TBL] [Abstract][Full Text] [Related]
43. Australian trial of topical minoxidil and placebo in early male pattern baldness.
Connors TJ; Cooke DE; De Launey WE; Downie M; Knudsen RG; Shumack S; Eggleston AS
Australas J Dermatol; 1990; 31(1):17-25. PubMed ID: 2073205
[TBL] [Abstract][Full Text] [Related]
44. Safety of topical minoxidil solution: a one-year, prospective, observational study.
Shapiro J
J Cutan Med Surg; 2003; 7(4):322-9. PubMed ID: 14735400
[TBL] [Abstract][Full Text] [Related]
45. Comparison of efficacy of platelet-rich plasma therapy with or without topical 5% minoxidil in male-type baldness: A randomized, double-blind placebo control trial.
Singh SK; Kumar V; Rai T
Indian J Dermatol Venereol Leprol; 2020; 86(2):150-157. PubMed ID: 31823902
[TBL] [Abstract][Full Text] [Related]
46. Clinical utility and validity of minoxidil response testing in androgenetic alopecia.
Goren A; Shapiro J; Roberts J; McCoy J; Desai N; Zarrab Z; Pietrzak A; Lotti T
Dermatol Ther; 2015; 28(1):13-6. PubMed ID: 25112173
[TBL] [Abstract][Full Text] [Related]
47. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia.
Gubelin Harcha W; Barboza Martínez J; Tsai TF; Katsuoka K; Kawashima M; Tsuboi R; Barnes A; Ferron-Brady G; Chetty D
J Am Acad Dermatol; 2014 Mar; 70(3):489-498.e3. PubMed ID: 24411083
[TBL] [Abstract][Full Text] [Related]
48. Intradermal injections with 0.5% minoxidil for the treatment of female androgenetic alopecia: A randomized, placebo-controlled trial.
Uzel BPC; Takano GHS; Chartuni JCN; Cesetti MV; Gavioli CFB; Lemes AM; Costa IMC
Dermatol Ther; 2021 Jan; 34(1):e14622. PubMed ID: 33269529
[TBL] [Abstract][Full Text] [Related]
49. An analysis of gene expression data involving examination of signaling pathways activation reveals new insights into the mechanism of action of minoxidil topical foam in men with androgenetic alopecia.
Stamatas GN; Wu J; Pappas A; Mirmirani P; McCormick TS; Cooper KD; Consolo M; Schastnaya J; Ozerov IV; Aliper A; Zhavoronkov A
Cell Cycle; 2017; 16(17):1578-1584. PubMed ID: 28594262
[TBL] [Abstract][Full Text] [Related]
50. The effectiveness of adding low-level light therapy to minoxidil 5% solution in the treatment of patients with androgenetic alopecia.
Faghihi G; Mozafarpoor S; Asilian A; Mokhtari F; Esfahani AA; Bafandeh B; Nouraei S; Nilforoushzadeh MA; Hosseini SM
Indian J Dermatol Venereol Leprol; 2018; 84(5):547-553. PubMed ID: 30027912
[TBL] [Abstract][Full Text] [Related]
51. Efficacy and safety of oral minoxidil in female androgenetic alopecia.
Vastarella M; Cantelli M; Patrì A; Annunziata MC; Nappa P; Fabbrocini G
Dermatol Ther; 2020 Nov; 33(6):e14234. PubMed ID: 32851744
[TBL] [Abstract][Full Text] [Related]
52. The Efficacy of Topical Minoxidil for Non-Scarring Alopecia: A Systematic Review.
Sung CT; Juhasz ML; Choi FD; Mesinkovska NA
J Drugs Dermatol; 2019 Feb; 18(2):155-160. PubMed ID: 30794366
[TBL] [Abstract][Full Text] [Related]
53. A randomized trial of minoxidil in chemotherapy-induced alopecia.
Duvic M; Lemak NA; Valero V; Hymes SR; Farmer KL; Hortobagyi GN; Trancik RJ; Bandstra BA; Compton LD
J Am Acad Dermatol; 1996 Jul; 35(1):74-8. PubMed ID: 8682968
[TBL] [Abstract][Full Text] [Related]
54. Topical cetirizine for treating androgenetic alopecia: A systematic review.
Chen X; Xiang H; Yang M
J Cosmet Dermatol; 2022 Nov; 21(11):5519-5526. PubMed ID: 35976065
[TBL] [Abstract][Full Text] [Related]
55. Androgenetic alopecia: treatment results with topical minoxidil.
Roberts JL
J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):705-10. PubMed ID: 3549805
[TBL] [Abstract][Full Text] [Related]
56. Efficacy of the association of topical minoxidil and topical finasteride compared to their use in monotherapy in men with androgenetic alopecia: A prospective, randomized, controlled, assessor blinded, 3-arm, pilot trial.
Rossi A; Caro G
J Cosmet Dermatol; 2024 Feb; 23(2):502-509. PubMed ID: 37798906
[TBL] [Abstract][Full Text] [Related]
57. Efficacy and safety of a novel herbal solution for the treatment of androgenetic alopecia and comparison with 5% minoxidil: A double-blind, randomized controlled trial study.
Masoud F; Alamdari HA; Asnaashari S; Shokri J; Javadzadeh Y
Dermatol Ther; 2020 Nov; 33(6):e14467. PubMed ID: 33112463
[TBL] [Abstract][Full Text] [Related]
58. Topical minoxidil for androgenetic alopecia: optimizing the chance for success by appropriate patient selection.
DeVillez RL
Dermatologica; 1987; 175 Suppl 2():50-3. PubMed ID: 3691914
[TBL] [Abstract][Full Text] [Related]
59. Multi-therapies in androgenetic alopecia: review and clinical experiences.
Rossi A; Anzalone A; Fortuna MC; Caro G; Garelli V; Pranteda G; Carlesimo M
Dermatol Ther; 2016 Nov; 29(6):424-432. PubMed ID: 27424565
[TBL] [Abstract][Full Text] [Related]
60. Topical minoxidil in early male pattern baldness.
Olsen EA; Weiner MS; Delong ER; Pinnell SR
J Am Acad Dermatol; 1985 Aug; 13(2 Pt 1):185-92. PubMed ID: 3900155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
